DataMeds AI and Tollo Health have joined forces with the National Football League Alumni Association’s subsidiary, Alumni Health, to initiate the Health Lives Here national health campaign. This strategic partnership is focused on enhancing the accessibility of healthcare information, pharmacy services, and health-management tools, with a particular emphasis on underserved and rural communities. By harnessing DataMeds AI’s extensive network of over 6,500 independent pharmacies, the initiative aims to boost awareness of healthy living while offering consumers discounted pharmacy services and other healthcare resources.
A significant component of this campaign is the forthcoming Health Lives Here mobile application, designed to be a consumer-centric telehealth and health-management platform. The app is set to enable users to merge electronic health records and integrate data from wearable devices into a single, centralized health dashboard. Additionally, the platform will offer access to pharmacy-based services and select healthcare products, facilitating a comprehensive approach to personal health management.
The Health Lives Here initiative was introduced to professional football alumni during the 2026 Football Hall of Fame Game weekend in Canton, Ohio. Plans for a wider public rollout are slated to commence in North Carolina in September 2026. Further details regarding the mobile application, participating pharmacies, and the overall campaign rollout are anticipated to be disclosed in due time.
This collaboration brings together Tollo Health’s expertise in medical food and nutraceutical products with DataMeds AI’s robust healthcare technology and pharmacy infrastructure. Moreover, the NFL Alumni Association’s health network will play a crucial role in reaching out to communities and former professional football players, ensuring a broad impact and engagement with the campaign’s objectives.
For media inquiries, contact James Lambert, Vice President of Rubenstein Public Relations, at 212-805-3024 or [email protected]. Investors can reach out via email at [email protected]. Additional information can be found on their website, https://datamedsai.com/.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.
